BridgeMD
Tests treatment safety and results for Schizophrenia
Official title A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
ClinicalTrials.gov ID: NCT07105111
What this study is testing
What is Valbenazine?
Valbenazine is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for schizophrenia.
Also referred to as NBI-98854.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- Diagnosed with one of the following at least 3 months prior to screening: schizophrenia or schizoaffective disorder, bipolar disorder, or major...
- Diagnosed with at least mild neuroleptic-induced TD for at least 3 months prior to screening Key
You likely can't join if
- Have comorbid Parkinsonism or abnormal involuntary movement(s) that is more prominent than TD
- Diagnosis of moderate or severe substance use disorder in the last 6 months
- History of long QT syndrome, cardiac arrythmia, or severe hepatic impairment
The study team makes the final eligibility decision.
Where it's taking place
- Bryant, Arkansas, United States
- Chino, California, United States
- Fountain Valley, California, United States
- Fresno, California, United States
- Long Beach, California, United States
- Orange, California, United States
- Redlands, California, United States
- San Diego, California, United States
- Bonita Springs, Florida, United States
- Hialeah, Florida, United States
- Miami, Florida, United States
- Orange City, Florida, United States
- Port Charlotte, Florida, United States
- Tampa, Florida, United States
- Augusta, Georgia, United States
- Marietta, Georgia, United States
- Naperville, Illinois, United States
- Omaha, Nebraska, United States
- Independence, Ohio, United States
- Austin, Texas, United States
+ 1 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bryant, Arkansas, United States; Chino, California, United States; Fountain Valley, California, United States; Fresno, California, United States; Long Beach, California, United States; Orange, California, United States and 15 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.